Citadel Advisors’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,700
| Closed | -$45.1K | – | 14786 |
|
|
2025
Q1 | $45.1K | Buy |
2,700
+1,900
| +238% | +$35K | ﹤0.01% | 12413 |
|
|
2024
Q4 | $15.1K | Sell |
800
-4,026
| -83% | -$77.6K | ﹤0.01% | 13374 |
|
|
2024
Q3 | $90.7K | Buy |
4,826
+4,084
| +550% | +$78.2K | ﹤0.01% | 11251 |
|
|
2024
Q2 | $14K | Sell |
742
-4,640
| -86% | -$79.1K | ﹤0.01% | 12906 |
|
|
2024
Q1 | $87.4K | Sell |
5,382
-5,197
| -49% | -$76.1K | ﹤0.01% | 11531 |
|
|
2023
Q4 | $134K | Sell |
10,579
-4,269
| -29% | -$53.9K | ﹤0.01% | 10569 |
|
|
2023
Q3 | $202K | Buy |
14,848
+10,022
| +208% | +$155K | ﹤0.01% | 9891 |
|
|
2023
Q2 | $82.8K | Sell |
4,826
-33,036
| -87% | -$512K | ﹤0.01% | 11202 |
|
|
2023
Q1 | $527K | Sell |
37,862
-7,239
| -16% | -$107K | ﹤0.01% | 8194 |
|
|
2022
Q4 | $603K | Buy |
+45,101
| New | +$583K | ﹤0.01% | 7855 |
|
|
2022
Q2 | – | Sell |
-27,469
| Closed | -$355K | – | 13974 |
|
|
2022
Q1 | $355K | Sell |
27,469
-3,526
| -11% | -$46.6K | ﹤0.01% | 10195 |
|
|
2021
Q4 | $491K | Buy |
30,995
+12,249
| +65% | +$209K | ﹤0.01% | 9743 |
|
|
2021
Q3 | $365K | Sell |
18,746
-9,280
| -33% | -$184K | ﹤0.01% | 10620 |
|
|
2021
Q2 | $638K | Sell |
28,026
-25,984
| -48% | -$539K | ﹤0.01% | 9470 |
|
|
2021
Q1 | $992K | Buy |
54,010
+35,079
| +185% | +$575K | ﹤0.01% | 8124 |
|
|
2020
Q4 | $282K | Buy |
+18,931
| New | +$247K | ﹤0.01% | 9178 |
|
|
2018
Q3 | – | Sell |
-23,200
| Closed | -$227K | – | 9641 |
|
|
2018
Q2 | $227K | Sell |
23,200
-54,566
| -70% | -$536K | ﹤0.01% | 7674 |
|
|
2018
Q1 | $723K | Buy |
77,766
+28,582
| +58% | +$272K | ﹤0.01% | 5279 |
|
|
2017
Q4 | $468K | Buy |
+49,184
| New | +$470K | ﹤0.01% | 5755 |
|
|
2016
Q1 | – | Sell |
-20,045
| Closed | -$129K | – | 7827 |
|
|
2015
Q4 | $129K | Buy |
20,045
+12,807
| +177% | +$80.1K | ﹤0.01% | 6402 |
|
|
2015
Q3 | $42K | Sell |
7,238
-23,200
| -76% | -$172K | ﹤0.01% | 7695 |
|
|
2015
Q2 | $266K | Buy |
30,438
+8,537
| +39% | +$71.7K | ﹤0.01% | 5924 |
|
|
2015
Q1 | $175K | Buy |
+21,901
| New | +$164K | ﹤0.01% | 6329 |
|
|
2014
Q4 | – | Sell |
-16,333
| Closed | -$106K | – | 8705 |
|
|
2014
Q3 | $106K | Buy |
16,333
+15,962
| +4,302% | +$123K | ﹤0.01% | 6353 |
|
|
2014
Q2 | $3K | Buy |
+371
| New | +$2.88K | ﹤0.01% | 7801 |
|
Other funds holding SEM
VPM
VCM
GCL
Citadel Advisors's SEM Position: Q1 2026 in Review
Citadel Advisors reduced its Select Medical (SEM) stake by 75% in Q1 2026, selling an estimated $2.6M and leaving 56,153 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #7861.
Citadel Advisors first reported a position in SEM in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.1M in Q1 2023. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Citadel Advisors held 56,153 shares of Select Medical worth $915K as of Q1 2026.
- Citadel Advisors sold 166,032 Select Medical shares in Q1 2026, an estimated $2.6M.
- Select Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7861 holding.
- Citadel Advisors first reported a position in Select Medical in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Select Medical position peaked at $10.1M in Q1 2023.
- 277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.